A study led by researchers from the Respiratory and Immune Repair (REPAIR) group at the Germans Trias i Pujol Research Institute (IGTP), in collaboration with researcher Daniel Closa from IIBB-CSIC, Enrique de-Madaria from ...
May 31, 2026
0
3
New research has shown that GLP‑1 weight-loss drugs deliver protection against heart attacks, strokes, and premature death over a sustained period of time. Researchers from Anglia Ruskin University (ARU) analyzed data from ...
Apr 30, 2026
0
11
A multicenter clinical trial published in JAMA has found that a long-used endoscopic procedure does not prevent recurrent pancreatitis in adults with an anatomic anomaly, challenging decades of conventional wisdom. The study, ...
Feb 2, 2026
0
8
A Europe-wide study led by the University Medical Center Göttingen (UMG) shows that the microbial composition of the gut, known as the gut microbiome, can predict long-term complications following severe acute pancreatitis. ...
Jan 20, 2026
0
13
Researchers from Mass General Brigham have found that olezarsen—a drug designed to lower triglyceride levels—can also decrease the risk of acute pancreatitis, a potential complication in patients with severely elevated triglyceride ...
Nov 10, 2025
0
18
The U.K. is asking patients whose pancreas became dangerously inflamed after taking obesity drugs like Wegovy and Zepbound to come in for tests to understand whether there's a genetic risk for the condition.
Jun 26, 2025
0
23
Academics at King's College London and the University of East Anglia have released guidance for GPs on how to manage patients who may be privately accessing weight loss drugs.
Jun 25, 2025
0
19
Acute pancreatitis is among the most common gastrointestinal conditions requiring inpatient hospital care in the United States.
Jun 18, 2025
0
15
Several years ago, a little-known drug named Ozempic—previously used only to treat diabetes—emerged as a promising new drug for weight management.
Jan 25, 2025
0
34
Tryngolza (olezarsen) has been approved by the U.S. Food and Drug Administration as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS), which can lead to potentially life-threatening ...
Dec 29, 2024
0
26
